MARÍA
DE LAGARDE SEBASTIÁN
Profesora asociada de Ciencias de la Salud
![Foto de MARÍA](/img/nophoto.png)
![Foto de Hospital Universitario 12 de Octubre](/img/noimage_org.png)
Hospital Universitario 12 de Octubre
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario 12 de Octubre (33)
2024
-
Fibrocavitary disease caused by Mycobacterium chimaera in a patient with HIV
AIDS
-
Life expectancy of people with HIV on antiretroviral therapy in Spain
AIDS, Vol. 38, Núm. 3, pp. 387-395
-
Transition times across the HIV care continuum in Spain from 2005 to 2022: a longitudinal cohort study
The Lancet HIV, Vol. 11, Núm. 7, pp. e470-e478
2023
-
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 11, pp. 2696-2701
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
-
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance
Open Forum Infectious Diseases, Vol. 9, Núm. 11
2021
-
Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery
The Journal of infectious diseases, Vol. 223, Núm. 3, pp. 471-481
2020
-
Sustained virological response at week 12 after interferon-free therapy as criterion for HCV cure definition: Validation in a real-life cohort of HIV-coinfected patients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 6, pp. 275-278
2019
-
Effects of immunonutrition in advanced human immunodeficiency virus disease: A randomized placebo-controlled clinical trial (Promaltia study)
Clinical Infectious Diseases, Vol. 68, Núm. 1, pp. 120-130
-
Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 4, pp. 725-734
-
Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles
Microbial Pathogenesis, Vol. 128, pp. 112-118
2018
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
-
Persistently altered liver test results in hepatitis C patients after sustained virological response with direct-acting antivirals
Journal of Viral Hepatitis, Vol. 25, Núm. 7, pp. 818-824
2017
-
Dual Therapy with Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy with Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial
Clinical Infectious Diseases, Vol. 65, Núm. 12, pp. 2112-2118
-
High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2102-2109
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2016
-
Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly
Journal of Infection, Vol. 72, Núm. 3, pp. 309-316